World Health Organization (WHO) report on priority medicines


Eurordis expressed serious reservations concerning the World Health Organization (WHO) Final Report on Priority Medicines for Europe and the World. Eurordis cited three shortcomings in the Report.
  • The inconsistency used throughout the Report when addressing rare diseases;
  • The limited geographical scope in regards to rare diseases (EU and the USA only);
  • The absence of a worldwide reflection on orphan drugs.
For more information: Eurordis’ newsletter article - April 2005


The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseases, Rare Diseases International is a EURORDIS initiativeRare Disease International Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect The Rare Barometer Programme is a EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases